Cyndeo Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Sell
17,927
-41
-0.2% -$41.9K 1.01% 15
2026
Q1
$16.5M Buy
17,968
+3,029
+20% +$3.07M 0.87% 28
2025
Q4
$16.1M Buy
14,939
+1,010
+7% +$966K 0.87% 30
2025
Q3
$10.6M Sell
13,929
-135
-1% -$100K 0.59% 41
2025
Q2
$11M Buy
14,064
+1,127
+9% +$876K 0.65% 38
2025
Q1
$10.7M Buy
12,937
+1,045
+9% +$870K 0.7% 35
2024
Q4
$9.18M Buy
11,892
+832
+8% +$689K 0.62% 43
2024
Q3
$9.8M Sell
11,060
-270
-2% -$243K 0.68% 33
2024
Q2
$10.3M Buy
11,330
+366
+3% +$293K 0.8% 31
2024
Q1
$8.53M Buy
10,964
+723
+7% +$515K 0.71% 31
2023
Q4
$5.97M Buy
10,241
+3,529
+53% +$2.06M 0.55% 50
2023
Q3
$3.61M Sell
6,712
-443
-6% -$228K 0.38% 89
2023
Q2
$3.36M Buy
7,155
+1,250
+21% +$524K 0.35% 94
2023
Q1
$2.03M Buy
5,905
+2,258
+62% +$762K 0.22% 124
2022
Q4
$1.33M Buy
+3,647
New +$1.29M 0.16% 150

Other funds holding LLY

Cyndeo Wealth Partners's LLY Position: Q2 2026 in Review

Cyndeo Wealth Partners reduced its Eli Lilly (LLY) stake by 0.23% in Q2 2026, selling an estimated $41.9K and leaving 17,927 shares worth $21.5M. The position accounts for 1.01% of the portfolio, ranked #15.

Cyndeo Wealth Partners first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cyndeo Wealth Partners held 17,927 shares of Eli Lilly worth $21.5M as of Q2 2026.
  • Cyndeo Wealth Partners sold 41 Eli Lilly shares in Q2 2026, an estimated $41.9K.
  • Eli Lilly made up 1.01% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #15 holding.
  • Cyndeo Wealth Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.